Comparison of shunt types in the Norwood procedure for single-ventricle lesions
- PMID: 20505177
- PMCID: PMC2891109
- DOI: 10.1056/NEJMoa0912461
Comparison of shunt types in the Norwood procedure for single-ventricle lesions
Abstract
Background: The Norwood procedure with a modified Blalock-Taussig (MBT) shunt, the first palliative stage for single-ventricle lesions with systemic outflow obstruction, is associated with high mortality. The right ventricle-pulmonary artery (RVPA) shunt may improve coronary flow but requires a ventriculotomy. We compared the two shunts in infants with hypoplastic heart syndrome or related anomalies.
Methods: Infants undergoing the Norwood procedure were randomly assigned to the MBT shunt (275 infants) or the RVPA shunt (274 infants) at 15 North American centers. The primary outcome was death or cardiac transplantation 12 months after randomization. Secondary outcomes included unintended cardiovascular interventions and right ventricular size and function at 14 months and transplantation-free survival until the last subject reached 14 months of age.
Results: Transplantation-free survival 12 months after randomization was higher with the RVPA shunt than with the MBT shunt (74% vs. 64%, P=0.01). However, the RVPA shunt group had more unintended interventions (P=0.003) and complications (P=0.002). Right ventricular size and function at the age of 14 months and the rate of nonfatal serious adverse events at the age of 12 months were similar in the two groups. Data collected over a mean (+/-SD) follow-up period of 32+/-11 months showed a nonsignificant difference in transplantation-free survival between the two groups (P=0.06). On nonproportional-hazards analysis, the size of the treatment effect differed before and after 12 months (P=0.02).
Conclusions: In children undergoing the Norwood procedure, transplantation-free survival at 12 months was better with the RVPA shunt than with the MBT shunt. After 12 months, available data showed no significant difference in transplantation-free survival between the two groups. (ClinicalTrials.gov number, NCT00115934.)
2010 Massachusetts Medical Society
Figures





Comment in
-
Hypoplastic left heart syndrome.N Engl J Med. 2010 May 27;362(21):2026-8. doi: 10.1056/NEJMe1002923. N Engl J Med. 2010. PMID: 20505182 No abstract available.
References
-
- Tabbutt S, Dominguez TE, Ravishankar C, et al. Outcomes after the stage I reconstruction comparing the right ventricular to pulmonary artery conduit with the modified Blalock Taussig shunt. Ann Thorac Surg. 2005;80:1582–1590. - PubMed
-
- Azakie A, Martinez D, Sapru A, Fineman J, Teitel D, Karl TR. Impact of right ventricle to pulmonary artery conduit on outcome of the modified Norwood procedure. Ann Thorac Surg. 2004;77:1727–1733. - PubMed
-
- Mahle WT, Cuadrado AR, Tam VK. Early experience with a modified Norwood procedure using right ventricle to pulmonary artery conduit. Ann Thorac Surg. 2003;76:1084–1088. - PubMed
-
- Mair R, Tulzer G, Sames E, et al. Right ventricular to pulmonary artery conduit instead of modified Blalock-Taussig shunt improves postoperative hemodynamics in newborns after the Norwood operation. J Thorac Cardiovasc Surg. 2003;126:1378–1384. - PubMed
-
- Pizarro C, Malec E, Maher KO, et al. Right ventricle to pulmonary artery conduit improves outcome after stage I Nor- wood for hypoplastic left heart syndrome. Circulation. 2003;108 Suppl 1 II-155-II-160. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- HL068288/HL/NHLBI NIH HHS/United States
- HL068285/HL/NHLBI NIH HHS/United States
- U01 HL068279/HL/NHLBI NIH HHS/United States
- U01 HL068290/HL/NHLBI NIH HHS/United States
- U10 HL068270/HL/NHLBI NIH HHS/United States
- U01 HL068281/HL/NHLBI NIH HHS/United States
- HL068290/HL/NHLBI NIH HHS/United States
- U01 HL068269/HL/NHLBI NIH HHS/United States
- U10 HL109816/HL/NHLBI NIH HHS/United States
- HL068279/HL/NHLBI NIH HHS/United States
- U01 HL068288/HL/NHLBI NIH HHS/United States
- U01 HL068270/HL/NHLBI NIH HHS/United States
- HL085057/HL/NHLBI NIH HHS/United States
- HL068281/HL/NHLBI NIH HHS/United States
- U01 HL068292/HL/NHLBI NIH HHS/United States
- HL068269/HL/NHLBI NIH HHS/United States
- HL068270/HL/NHLBI NIH HHS/United States
- U01 HL085057/HL/NHLBI NIH HHS/United States
- U10 HL109778/HL/NHLBI NIH HHS/United States
- U01 HL068285/HL/NHLBI NIH HHS/United States
- HL068292/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical